Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 314, Issue 2, pp 183–190 | Cite as

Histamine-Induced release of arachidonic acid and of prostaglandins in the peripheral vascular bed

Mode of action
  • Heinz Juan
  • Wolfgang Sametz


  1. 1.

    Injection or infusion of histamine intraarterially into the isolated perfused rabbit ear dosedependently stimulated the release of prostaglandins (PGs) as measured by radioimmunoassay (PGE), bovine coronary artery strips (PGI2) and by the prelabeling technic with [1-14C]-arachidonic acid (PGI2, PGE2, PGF, PGD2).

  2. 2.

    PG release was abolished by indometacin (1–3 μg/ml) and reduced by the phospholipase A2 inhibitor quinacrine (10 μg/ml) as well as by perfusing with calcium-free, 1 mM EGTA containing solution.

  3. 3.

    The histamine H2-receptor antagonists burimamide (5μg/ml) and cimetidine (2 μg/ml) did not influence histamine-induced PG release. The H1-receptor antagonist mepyramine (0.1–1 μg/ml) abolished histamine-induced PG release.

  4. 4.

    In the presence, but not in the absence, of bovine serum albumin there was a basal release of high amounts of arachidonic acid. Histamine tended to increase the released amount of radioactive arachidonic acid. In contrast to indometacin which only blocked PG release, mepyramine significantly reduced the histamine-stimulated release of arachidonic acid, too.

  5. 5.

    The results show that in the peripheral vascular bed, histamine, via H1-receptors, activates a phospholipase A2 mainly by increasing a transfer of extracellular calcium into the cell. Activation of a phospholipase A2 results in the release of arachidonic acid possibly from a rather small endogenous pool which specifically provides substrate for the PG synthetase system.


Key words

Histamine PG release [1-14C]-Arachidonic acid Phospholipase A2 Calcium H1 receptor 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bakhle YS, Smith TW (1972) Release of spasmogenic substances induced by vasoactive amines from isolated lungs. Br J Pharmacol 46:543P-544PGoogle Scholar
  2. Berti F, Folco GC, Nicosia S, Omini C, Pasargiklian R (1979) The role of histamine H1-and H2-receptors in the generation of thromboxane A2 in perfused guinea-pig lungs. Br J Pharmacol 65:629–633Google Scholar
  3. Blackwell GJ, Duncombe WG, Flower RJ, Parsons MF, Vane JR (1977) The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs. Br J Pharmacol 59:353–366Google Scholar
  4. Blackwell GJ, Flower RJ, Nijkamp FP, Vane JR (1978) Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation and inhibition by anti-inflammatory steroids. Br J Pharmacol 62:79–89Google Scholar
  5. Chal JS, Chal LA (1976) The role of prostaglandins in chemically induced inflammation. Br J Exp Pathol 57:689–695Google Scholar
  6. Creese BR, Denborough MA (1979) Negative feedback regulation of airways smooth muscle contraction by prostaglandins and cyclic AMP. Proc Aust Biochem Soc 12:44Google Scholar
  7. Damas J, Deby C (1976) Sur la libération des prostaglandines et de leur précurseurs, par la bradykinine. Arch Int Physiol Biochim 84:293–304Google Scholar
  8. Derksen A, Cohen P (1975) Patterns of fatty acid release from endogenous substrates by human platelet homogenates and membranes. J. Biol Chem 250:9342–9347Google Scholar
  9. Ferreira SH, Moncada S, Vane JR (1973) Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharmacol 49:86–97Google Scholar
  10. Flower RJ, Blackwell GJ (1977) The importance of phospholipase A2 in prostaglandin biosynthesis. Biochem Pharmacol 25:285–291Google Scholar
  11. Gryglewski RJ (1977) Generation of prostaglandin and thromboxane-like substances by large airways and lung parenchymia. In: Berti F, Samuelsson B, Velo GP (eds) Prostaglandins and thromboxanes. Plenum Press, New York and London, pp 165–178Google Scholar
  12. De Haas GH, Postema NM, Nieuwenhuizen W, Van Deenen LLM (1968) Purification and properties of phospholipase A from procine pancreas. Biochim. Biophys Acta 159:103–117Google Scholar
  13. Halpern BN, Neveu T, Spector S (1963) On the nature of the chemical mediators involved in anaphylactic reactions in mice. Br J Pharmacol 20:389–398Google Scholar
  14. Hamberg M, Svenson J, Samuelsson B (1975) Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72:2994–2998Google Scholar
  15. Herman AG, Claeys M, Moncada S, Vane JR (1979) Biosynthesis of prostacyclin PGI2 and 12-l-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE) by pericardium, pleura, peritoneum and aorta of the rabbit. Prostaglandins 18:439–452Google Scholar
  16. Isakson PC, Raz A, Needleman P (1976) Selective incorporation of [14C]-arachidonic acid into the phospholipids of intact tissues and subsequent metabolism to [14C]-prostaglandins. Prostaglandins 12:739–748Google Scholar
  17. Isakson PC, Raz A, Denny SE, Wyche A, Needleman P (1977) Hormonal stimulation of arachidonic release from isolated perfused organs. Relationship to prostaglandin biosynthesis. Prostaglandins 14:853–871Google Scholar
  18. Juan H (1977) Mechanism of action of bradykinin-induced release of prostaglandin E. Naunyn-Schmiedeberg's Arch Pharmacol 300:77–85Google Scholar
  19. Juan H (1978) Prostaglandins as modulator of pain: Minirev. Gen Pharmacol 9: 403–409Google Scholar
  20. Juan H (1979a) Role of calcium in prostaglandin E release induced by bradykinin and the ionophore A 23187. Naunyn-Schmiedeberg's Arch Pharmacol 307:177–183Google Scholar
  21. Juan H (1979b) Prostaglandin release by histamine due to stimulation of H1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 308:R27Google Scholar
  22. Juan H, Lembeck F (1974) Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit car. Naunyn-Schmiedeberg's Arch. Pharmacol 283:151–164Google Scholar
  23. Juan H, Lembeck F (1976a) Polyphloretin phosphate reduces the algesic action of bradykinin by interfering with E-type prostaglandins. Agents Actions 6:646–650Google Scholar
  24. Juan H, Lembeck F (1976b) Release of prostaglandins from the isolated perfused rabbit ear by bradykinin and acetylcholine. Agents Actions 6:642–645Google Scholar
  25. Juan H, Sametz W (1980) Release of incorporated[14C]-arachidonate from the perfused rabbit ear and subsequent metabolism to [14C]-prostaglandins. Naunyn-Schmiedeberg's Arch Pharmacol 311:R30Google Scholar
  26. Kunze H, Bohn E, Vogt E (1974) Effects of local anaesthetics on prostaglandin biosynthesis in vitro. Biochim Biophys Acta 360:260–269Google Scholar
  27. Laekeman GM, Herman AG (1978) Release of prostaglandin-like material by various agonists from the guinea-pig lung and intestine. Arch Int Pharmacodyn Ther 236:307–309Google Scholar
  28. Lembeck F, Popper H, Juan H (1976) Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect. Naunyn-Schmiedeberg's Arch Pharmacol 294:69–73Google Scholar
  29. Liebig R, Bernauer W, Peskar BA (1974) Release of prostaglandins, a prostaglandin metabolite, slow-reacting substance and histamine from anaphylactic lungs, and its modification by catecholamine. Naunyn-Schmiedeberg's Arch Pharmacol 284:279–293Google Scholar
  30. Logan G, Wilhelm DL (1966) Vascular permeability changes in inflammation. I. The role of endogenous permeability factors in ultraviolet injury. Br J Exp Path 47:300–314Google Scholar
  31. Markus HB, Ball EG (1969) Inhibition of lipolytic processes in rat adipose tissue by antimalarial drugs. Biochim Biophys Acta 187:486–491Google Scholar
  32. Moncada S, Ferreira SH, Vane JR (1975) Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint. Eur J Pharmacol 31:250–260Google Scholar
  33. Omini C, Moncada S, Vane JR (1977) The effect of prostacyclin (PGI2) on tissues which detect prostaglandins (PG's). Prostaglandins 14:625–632Google Scholar
  34. Piper PJ, Vane JR (1969) Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 223: 29–35Google Scholar
  35. Plaut M, Lichtenstein LM (1978) Histamine, 5-hydroxytryptamin, SRS-A: Discussion of type I hypersensitivity (anaphylaxis). In: Vane JR, Ferreira SH (eds) Inflammation. Springer, Berlin Heidelberg New York, pp 345–373Google Scholar
  36. Rosenthal SR (1977) Histamine as the chemical mediator for cutaneous pain. J Invest Dermatol 69:98–105Google Scholar
  37. Starr MS, West GB (1967) Bradykinin and oedema formation in heated paws of rats. Br J Pharmacol 31:178–187Google Scholar
  38. Sun FF, Chapman JP, McGuire JC (1977) Metabolism of prostaglandin endoperoxide in animal tissues. Prostaglandins 14: 1055–1074Google Scholar
  39. Vargaftig BB, Dao Hai N (1972) Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykinin. J Pharm Pharmacol 24:159–161Google Scholar
  40. Wilhelm DL (1973) Chemical mediators. In: Zweifach BW, Grant L, McCluskey RT (eds) The inflammatory process, 2nd Ed. vol II. Academic Press, New York-London, pp 251–301Google Scholar
  41. Wilkinson DI, Walsh JT (1977) Prostaglandin biosynthesis in the epidermis and dermis of young mouse skin, and the effects of calcium and cyclic nucleotides. J Invest Dermatol 68:210–214Google Scholar
  42. Yen S-S, Mathe AA, Dugan JJ (1976) Release of prostaglandins from healthy and sensitized guinea-pig lung and trachea by histamine. Prostaglandins 11:227–239Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • Heinz Juan
    • 1
  • Wolfgang Sametz
    • 1
  1. 1.Institut f. Experimentelle u. Klinische Pharmakologie der Universität GrazGrazAustria

Personalised recommendations